Zaba O - Search Results

1

Detection and Quantification of Delamination Failures in Marine Composite Bulkheads via Vibration Energy Variations.

Garcia C, Jurado A, Zaba O, Beltran P. Garcia C, et al. Among authors: zaba o. Sensors (Basel). 2021 Apr 17;21(8):2843. doi: 10.3390/s21082843. Sensors (Basel). 2021. PMID: 33920715 Free PMC article.

2

Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors.

Heigener DF, Schumann C, Sebastian M, Sadjadian P, Stehle I, Märten A, Lüers A, Griesinger F, Scheffler M; Afatinib Compassionate Use Consortium (ACUC). Heigener DF, et al. Oncologist. 2015 Oct;20(10):1167-74. doi: 10.1634/theoncologist.2015-0073. Epub 2015 Sep 9. Oncologist. 2015. PMID: 26354527 Free PMC article.

3

Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease.

Hoffknecht P, Tufman A, Wehler T, Pelzer T, Wiewrodt R, Schütz M, Serke M, Stöhlmacher-Williams J, Märten A, Maria Huber R, Dickgreber NJ; Afatinib Compassionate Use Consortium (ACUC). Hoffknecht P, et al. J Thorac Oncol. 2015 Jan;10(1):156-63. doi: 10.1097/JTO.0000000000000380. J Thorac Oncol. 2015. PMID: 25247337 Free PMC article.

4

Experience with afatinib in patients with non-small cell lung cancer progressing after clinical benefit from gefitinib and erlotinib.

Schuler M, Fischer JR, Grohé C, Gütz S, Thomas M, Kimmich M, Schneider CP, Laack E, Märten A; Afatinib Compassionate Use Consortium. Schuler M, et al. Oncologist. 2014 Oct;19(10):1100-9. doi: 10.1634/theoncologist.2014-0103. Epub 2014 Sep 17. Oncologist. 2014. PMID: 25232040 Free PMC article.

5

LKB1 mutant in a KRAS activated adenocarcinoma of the lung associated with Peutz-Jeghers syndrome: a case report.

Zaba O, Holbe D, Aretz S, Grohé C. Zaba O, et al. Lung Cancer. 2013 Nov;82(2):368-9. doi: 10.1016/j.lungcan.2013.08.019. Epub 2013 Sep 2. Lung Cancer. 2013. PMID: 24054548

6

[Management of tumors with neuroendocrine differentiation].

Haug A, Pfluger T, Schnabel PA, Zaba O. Haug A, et al. Among authors: zaba o. Onkologie. 2013;36 Suppl 6:9-13. doi: 10.1159/000353717. Epub 2013 Aug 12. Onkologie. 2013. PMID: 23989043 Free article. German. No abstract available.

7

A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan.

Petereit C, Zaba O, Teber I, Lüders H, Grohé C. Petereit C, et al. Among authors: zaba o. BMC Pulm Med. 2013 Aug 29;13:55. doi: 10.1186/1471-2466-13-55. BMC Pulm Med. 2013. PMID: 23987478 Free PMC article. Clinical Trial.

8

[Is hyponatremia a prognostic marker of survival for lung cancer?].

Petereit C, Zaba O, Teber I, Grohé C. Petereit C, et al. Among authors: zaba o. Pneumologie. 2011 Sep;65(9):565-71. doi: 10.1055/s-0030-1256668. Epub 2011 Aug 11. Pneumologie. 2011. PMID: 21837588 Free article. German.

9

Novel therapies in non-small cell lung cancer.

Zaba O, Grohe C, Merk J. Zaba O, et al. Minerva Chir. 2011 Jun;66(3):235-44. Minerva Chir. 2011. PMID: 21666560 Review.

10

[Concept for a forward-looking communication in the palliative treatment of patients with pneumological-oncological diseases prospective].

Tessmer G, Zaba O, Grohé C. Tessmer G, et al. Among authors: zaba o. Pneumologie. 2011 Aug;65(8):503-9. doi: 10.1055/s-0030-1256307. Epub 2011 Mar 24. Pneumologie. 2011. PMID: 21437857 Free article. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page